# Antiplatelet Effect of Ginkgo Diterpene Lactone Meglumine Injection in Acute Ischemic Stroke

> **NCT05531942** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Shanghai Yueyang Integrated Medicine Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Ginkgo Diterpene Lactone Meglumine Injection
- **DRUG:** Acetylsalicylic acid

## Key facts

- **NCT ID:** NCT05531942
- **Lead sponsor:** Shanghai Yueyang Integrated Medicine Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2023-10-01
- **Final completion:** 2023-11-01
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05531942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05531942, "Antiplatelet Effect of Ginkgo Diterpene Lactone Meglumine Injection in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05531942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*